These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32191414)

  • 21. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.
    Schuetz P; Bolliger R; Merker M; Christ-Crain M; Stolz D; Tamm M; Luyt CE; Wolff M; Schroeder S; Nobre V; Reinhart K; Branche A; Damas P; Nijsten M; Deliberato RO; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Beishuizen A; de Jong E; Briel M; Welte T; Mueller B
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):555-564. PubMed ID: 29969320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.
    Andriolo BN; Andriolo RB; Salomão R; Atallah ÁN
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010959. PubMed ID: 28099689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients.
    Matthaiou DK; Ntani G; Kontogiorgi M; Poulakou G; Armaganidis A; Dimopoulos G
    Intensive Care Med; 2012 Jun; 38(6):940-9. PubMed ID: 22538461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.
    Stocker M; Hop WC; van Rossum AM
    BMC Pediatr; 2010 Dec; 10():89. PubMed ID: 21143869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
    Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
    BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Annane D; Reinhart K; Falsey AR; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Oliveira CF; Maravić-Stojković V; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Corti C; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Briel M; Mueller B
    Lancet Infect Dis; 2018 Jan; 18(1):95-107. PubMed ID: 29037960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    Abdul-Aziz MH; Hammond NE; Brett SJ; Cotta MO; De Waele JJ; Devaux A; Di Tanna GL; Dulhunty JM; Elkady H; Eriksson L; Hasan MS; Khan AB; Lipman J; Liu X; Monti G; Myburgh J; Novy E; Omar S; Rajbhandari D; Roger C; Sjövall F; Zaghi I; Zangrillo A; Delaney A; Roberts JA
    JAMA; 2024 Aug; 332(8):638-648. PubMed ID: 38864162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis.
    Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z
    Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 34. [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials].
    Zhang L; Huang J; Xu T; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):275-82. PubMed ID: 22781200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit.
    Katz SE; Crook J; Gillon J; Stanford JE; Wang L; Colby JM; Banerjee R
    Pediatr Infect Dis J; 2021 Apr; 40(4):333-337. PubMed ID: 33181782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.
    Li Z; Yuan X; Yu L; Wang B; Gao F; Ma J
    Medicine (Baltimore); 2019 Aug; 98(32):e16775. PubMed ID: 31393400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.